Objective There are numerous reported cases of extended-spectrum beta-lactamases
(ESBLs) producing Enterobacteriaceae in Nigeria. Yet, there are regions in Nigeria where …

Background: Extended spectrum β-lactamases (ESBLs) have emerged as a major threat
worldwide, with limited treatment options available. Objectives: The present study aimed to …

Background Bacteremia is a leading cause of mortality in developing countries, however,
etiologic evaluation is infrequent and empiric antibiotic use not evidence-based. Here, we …

Background: The emergence and spread of Extended-spectrum β-lactamases (ESBLs) in
Enterobacteriaceae through the plasmid-mediated exchange have become a major threat to …

I n 1882, Carl Friedlander described Klebsiella pneumoniae for the first time. He described it
as an encapsulated bacillus after isolating the bacterium from the lungs of those who had …

Background and objectives: The discovery of plasmid-mediated quinolone resistance
(PMQR) in the late 1990's added a new dimension to quinolone resistance. During the last …

Introduction: ESBLs are a B-lactamases which had ability to hydrolyse third-generation
cephalosporins and aztreonam. ESBLs producer bacteria are resistant to a wide variety of …

Rickettsioses are a group of vector-borne diseases that have come to the limelight in Sri
Lanka during the last two decades. Evidence for spotted fever group rickettsioses, scrub …

The use of antibiotics in veterinary and human treatment can cause the development of
antibiotic resistance in bacteria for β-lactam antibiotics. Worldwide, this resistance has …

The study, aimed at determining the prevalence and antibiotic resistance pattern of
extendedspectrum beta-lactamase (ESBL)-producing Escherichia coli from wound infections …